APOA1 and type 2 diabetes mellitus: Daily CrBJ supplementation for 60 days increased paraoxonase-1 (PON-1) and apolipoprotein (Apo)A-I expression (dysfunctioning of PON-1 and apoA-I results in glycation in T2DM patients) accompanied by decreased blood glucose and ApoB levels in T2DM patients.